In Vivo Study to Evaluate Tissue Remodeling Via Fibroblast Stimulation Following a Single SofWave Treatment
NCT: NCT07685821 · ACTIVE_NOT_RECRUITING
NCT IDNCT07685821
StatusACTIVE_NOT_RECRUITING
Start Date2025-12-22
Completion2026-12
SponsorSofwave Medical LTD (INDUSTRY)
First posted
Last updated
Brief Summary
Open-label, non-randomized single-arm prospective, single-center, self-controlled clinical study.
Frequently Asked Questions
What is In Vivo Study to Evaluate Tissue Remodeling Via Fibroblast Stimulation Following a Single SofWave Treatment?
In Vivo Study to Evaluate Tissue Remodeling Via Fibroblast Stimulation Following a Single SofWave Treatment is a clinical trial registered under NCT07685821. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT07685821?
The current status of NCT07685821 (In Vivo Study to Evaluate Tissue Remodeling Via Fibroblast Stimulation Following a Single SofWave Treatment) is: ACTIVE_NOT_RECRUITING.
When did In Vivo Study to Evaluate Tissue Remodeling Via Fibroblast Stimulation Following a Single SofWave Treatment start?
In Vivo Study to Evaluate Tissue Remodeling Via Fibroblast Stimulation Following a Single SofWave Treatment started on 2025-12-22.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.